sglt2 inhibitors and glp-1 receptor agonists Frontiers GLP-1 receptor agonists and SGLT2
Description
The entero-endocrine-osseous axis involves gastrointestinal substrates for DPP-4, including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptides 1 (GLP-1) and 2 (GLP-2)
10.1016/0014-5793(94)01430-9 88 WeldyC
[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Wang C, Kang C, Xian Y, Zhang M, Chen X, et al
O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, et al
A grandmother who used Saxenda to drop 35 pounds and reduce her joint pain enough to play with her grandchildren again
The choice between Jardiance and Ozempic depends on individual health needs and treatment goals
